|
SENP7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.90330004482087E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2299999999632E-06 |
| Normal-vs-Stage2 |
2.75239999680821E-08 |
| Normal-vs-Stage3 |
4.60160021198419E-10 |
| Normal-vs-Stage4 |
7.36080000285355E-08 |
| Stage1-vs-Stage2 |
3.281800E-02 |
| Stage1-vs-Stage3 |
5.778400E-03 |
| Stage1-vs-Stage4 |
1.379870E-02 |
| Stage2-vs-Stage3 |
9.405400E-01 |
| Stage2-vs-Stage4 |
7.824200E-01 |
| Stage3-vs-Stage4 |
6.972800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66040003968249E-09 |
| Normal-vs-AfricanAmerican |
8.977500E-03 |
| Normal-vs-Asian |
1.340810E-03 |
| Caucasian-vs-AfricanAmerican |
2.998400E-01 |
| Caucasian-vs-Asian |
1.144380E-01 |
| AfricanAmerican-vs-Asian |
9.162600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57030000003111E-06 |
| Normal-vs-Female |
1.64960001214354E-09 |
| Male-vs-Female |
5.123600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.54412999999742E-05 |
| Normal-vs-Age(41-60Yrs) |
2.6562000376984E-09 |
| Normal-vs-Age(61-80Yrs) |
2.87589999592441E-08 |
| Normal-vs-Age(81-100Yrs) |
1.816620E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.995550E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.527690E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.691800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.952000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.463800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.132800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.606300E-04 |
| Classical-VS-Follicular |
9.393000E-01 |
| Classical-VS-Other |
5.927200E-01 |
| Classical-VS-Normal |
9.64449999862893E-08 |
| Tall-VS-Follicular |
4.060900E-03 |
| Tall-VS-Other |
2.699900E-02 |
| Tall-VS-Normal |
3.06299996477577E-09 |
| Follicular-VS-Other |
6.254600E-01 |
| Follicular-VS-Normal |
3.76149999999909E-05 |
| Other-VS-Normal |
1.220570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.2762000012323E-08 |
| Normal-vs-N1 |
6.382200E-04 |
| N0-vs-N1 |
3.523800E-01 |
|
|
